Cheaper version of ustekinumab tested for painful Behçet's ulcers
NCT ID NCT07244614
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is observing 208 adults with Behçet's syndrome who have painful mouth and genital ulcers that did not improve with standard treatments. Researchers are tracking how well a biosimilar (a copy) of the drug ustekinumab controls these ulcers over 24 weeks, and comparing results to patients taking another drug called apremilast. No extra tests or visits are added—just routine care data is collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- biosimilar of ustekinumab
- What this could lead to
- If successful, this could show that a more affordable biosimilar version of ustekinumab is effective for controlling painful mouth and genital ulcers in Behçet's syndrome.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. The biosimilar may not work as well as the original drug, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHÇET'S SYNDROME (BS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP-Hôpital COCHIN
NOT_YET_RECRUITINGParis, France
-
APHP_ Hôpital Pitié-Salpêtrière
RECRUITINGParis, Île-de-France Region, 75013, France
-
APHP_Hopital Lariboisière
ACTIVE_NOT_RECRUITINGParis, Île-de-France Region, 75010, France
-
CHU BORDEAUX Hôpital Saint-André - Service de médecine interne
NOT_YET_RECRUITINGBordeaux, France
-
CHU Rouen_Hôpital Charles Nicolle
NOT_YET_RECRUITINGRouen, 76000, France
-
CHU de Rouen - service dermatologie
NOT_YET_RECRUITINGRouen, France
-
GHSIF Melun
RECRUITINGMelun, 77000, France
-
HOPITAL CROIX-ROUSSE - HCL - service de médecine interne
NOT_YET_RECRUITINGLyon, France
-
Hospices civils de Lyon
NOT_YET_RECRUITINGLyon, France
-
Service de médecine interne-APHP - Henri Mondor
NOT_YET_RECRUITINGCréteil, 94000, France
-
service de dermatologie - APHP - St Louis
NOT_YET_RECRUITINGParis, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.